Onyx Moving to South SF

Xconomy San Francisco — 

Onyx Pharmaceuticals (NASDAQ: ONXX) is moving its headquarters from Emeryville, CA to a space in South San Francisco vacated by Exelixis, according to this report in the San Francisco Business Times. Onyx, which co-markets the hit cancer drug sorafenib (Nexavar), plans to move 220 employees to the facility at 249 E. Grand Avenue, according to the newspaper. The space was freed up after Exelixis cut about 270 jobs at its South San Francisco headquarters in March.